ClinicalTrials.gov record
Recruiting Phase 2Phase 3 Interventional

Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)

ClinicalTrials.gov ID: NCT05714085

Public ClinicalTrials.gov record NCT05714085. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 5, 2026, 7:20 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2/3 Randomized, Placebo-Controlled, Double-blind, Clinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Systemic Left Ventricular Systolic Dysfunction (VALOR)

Study identification

NCT ID
NCT05714085
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2, Phase 3
Lead sponsor
Merck Sharp & Dohme LLC
Industry
Enrollment
342 participants

Conditions and interventions

Interventions

  • Placebo suspension Drug
  • Placebo tablet Drug
  • Vericiguat suspension Drug
  • Vericiguat tablet Drug

Drug

Eligibility (public fields only)

Age range
29 Days to 17 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 30, 2023
Primary completion
Apr 14, 2032
Completion
Apr 14, 2032
Last update posted
Apr 19, 2026

2023 – 2032

United States locations

U.S. sites
20
U.S. states
14
U.S. cities
20
Facility City State ZIP Site status
The Regents of the University of California - Los Angeles (UCLA Pediatrics) ( Site 0002) Los Angeles California 90095 Recruiting
Lucile Packard Children's Hospital ( Site 0040) Palo Alto California 94304 Recruiting
Loma Linda University Health System ( Site 0008) San Bernardino California 92408 Recruiting
Children's Hospital Colorado ( Site 0012) Aurora Colorado 80045 Recruiting
Children's National Medical Center ( Site 0020) Washington D.C. District of Columbia 20010 Recruiting
Johns Hopkins All Children's Hospital ( Site 0029) St. Petersburg Florida 33701 Recruiting
Children's Healthcare of Atlanta - Arthur M. Blank Hospital ( Site 0001) Atlanta Georgia 30329 Recruiting
Boston Children's Hospital ( Site 0035) Boston Massachusetts 02115 Recruiting
C.S. Mott Children's Hospital ( Site 0033) Ann Arbor Michigan 48109 Recruiting
Washington University-Pediatric Cardiology/ St. Louis Children's Hospital ( Site 0006) St Louis Missouri 63110 Recruiting
Columbia University Medical Center-Pediatric Cardiology ( Site 0016) New York New York 10032 Recruiting
The Children's Hospital at Montefiore ( Site 0030) The Bronx New York 10467 Recruiting
Cincinnati Children's Hospital Medical Center ( Site 0034) Cincinnati Ohio 45229 Recruiting
Cleveland Clinic-Cleveland Clinic Chidren's ( Site 0022) Cleveland Ohio 44195 Recruiting
Children's Hospital of Philadelphia (CHOP) ( Site 0004) Philadelphia Pennsylvania 19104 Recruiting
Children's Hospital of Pittsburgh ( Site 0010) Pittsburgh Pennsylvania 15224 Recruiting
Le Bonheur Children's Hospital ( Site 0007) Memphis Tennessee 38103 Recruiting
Children's Health-The Heart Center ( Site 0015) Dallas Texas 75235 Recruiting
Texas Children's Hospital ( Site 0039) Houston Texas 77030 Recruiting
Seattle Children's Hospital-Cardiology/Fetal Therapy ( Site 0019) Seattle Washington 98105 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 85 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05714085, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 19, 2026 · Synced May 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05714085 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →